2026 NPPES data Surgical Oncology Physician NPI 1700049566 M.D.
Verify on CMS →

DEBORAH FARR, M.D.

Surgical Oncology Physician in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
123
Medicare Part D claims · 62 beneficiaries · Surgical Oncology Physician avg: 97
MIPS score
74.5984/100
▼ 9 pts below national avg 83.1 · [object Object]
What the federal data reveals: DEBORAH FARR, M.D. is a Surgical Oncology Physician ([object Object]) practicing in DALLAS, Texas with a Medicare Part D prescribing footprint of 123 claims across 62 beneficiaries . Their CMS MIPS Final Score of 74.5984/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: DEBORAH FARR, M.D. reported a CMS MIPS final score of 74.5984 out of 100, below the 83.1 national average, and filed 123 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

DEBORAH FARR, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

DEBORAH FARR, M.D. at a glance

Below national average

NPI registry status

Active

Issued 07/02/2008

NPI 1700049566

Primary specialty

Surgical Oncology Physician

Niche

1,410 US NPIs in this specialty

Medicare Part D claims

123 27% vs specialty avg

2023 prescription claims

Specialty avg: 97

MIPS final score

74.5984/100 8.501599999999996% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Texas

How Surgical Oncology Physician compares to other specialties among Texas providers

Texas providers

Surgical Oncology Physician share within Texas

1. Surgical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Surgical Oncology Physician share within Texas

Medicare quality performance — MIPS

DEBORAH FARR, M.D.'s 2023 MIPS final score plotted against the Surgical Oncology Physician national average

Below national average
MIPS Final Score
74.5984/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Surgical Oncology Physician) — 74.5984/100 vs national avg 83.1

0%100%National avg83%74.6%
MIPS final score (Surgical Oncology Physician) — 74.5984/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEBORAH FARR, M.D. is a Surgical Oncology Physician provider practicing in DALLAS, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1700049566. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DEBORAH FARR, M.D. appears in the CMS NPPES registry as a Surgical Oncology Physician provider holding M.D. credentials at 5323 HARRY HINES BLVD, DALLAS, TX, 75390, with a listed phone of (214) 645-0624. NPI 1700049566 was issued on 07/02/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FARR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 123 prescription claims written by this provider, covering 62 Medicare beneficiaries and totaling roughly $919 in drug spend, with an opioid prescribing rate of 36.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.5984/100 for the 2023 performance year (Quality 56.1252, Cost 59.2027), compared with the national average of 83.1.

Surgical Oncology Physician is a narrow specialty nationwide, with 1,410 enrolled providers across 50 states and an average of 97 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5323 HARRY HINES BLVD
DALLAS, TX 75390

Provider Details

NPI 1700049566
Specialty Surgical Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 07/02/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

74.5984
Final Score
Avg: 83.1
56.1252
Quality
59.2027
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where DEBORAH FARR, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
DALLAS, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to DEBORAH FARR, M.D.. To verify DEBORAH FARR, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

123
Total Claims
$919
Total Drug Cost
62
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
125
Total Day Supply
988
Brand Drug Cost
$0
Generic Drug Cost
$919
Opioid Claims
45 (36.6% rate)
Antibiotic Claims
25

Patient Demographics

Average Patient Age
71.3 years
Avg HCC Risk Score
1.10

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Celecoxib
32
Oxycodone Hcl
27
Cephalexin
19
Tramadol Hcl
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Surgical Oncology Physician Overview

How DEBORAH FARR, M.D. fits within the Surgical Oncology Physician landscape nationally.

1,410
Surgical Oncology Physician Providers in US
50
States with Surgical Oncology Physician
97
Avg Claims per Provider

DEBORAH FARR, M.D.'s 123 claims are above the specialty average of 97.

Nearby Surgical Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as FARR.

Compare Surgical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEBORAH FARR, M.D.'s specialty?
DEBORAH FARR, M.D. specializes in Surgical Oncology Physician and practices in DALLAS, Texas. Credentials: M.D..
How much does DEBORAH FARR, M.D. prescribe under Medicare Part D?
In 2023, DEBORAH FARR, M.D. wrote 123 Medicare Part D claims totaling $919 in drug costs for 62 beneficiaries.
What is DEBORAH FARR, M.D.'s Medicare quality score?
DEBORAH FARR, M.D. has a CMS MIPS Final Score of 74.5984/100 (Quality: 56.1252, Cost: 59.2027). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DEBORAH FARR, M.D. located?
DEBORAH FARR, M.D. is located at 5323 HARRY HINES BLVD, DALLAS, TX, 75390. Phone: (214) 645-0624.
What is DEBORAH FARR, M.D.'s NPI number?
DEBORAH FARR, M.D.'s National Provider Identifier (NPI) is 1700049566, issued on 07/02/2008.
Does DEBORAH FARR, M.D. prescribe opioids?
Yes, DEBORAH FARR, M.D. had 45 opioid claims in 2023 with an opioid prescribing rate of 36.6%.
How many Surgical Oncology Physician providers are there in the US?
There are 1,410 Surgical Oncology Physician providers across 50 states in the US. The average Surgical Oncology Physician provider writes 97 Medicare Part D claims per year.
What drugs does DEBORAH FARR, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DEBORAH FARR, M.D.'s most frequently prescribed drugs include Celecoxib, Oxycodone Hcl, Cephalexin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEBORAH FARR, M.D. accept Medicare?
DEBORAH FARR, M.D. appears in CMS Medicare data with 123 Part D claims and 62 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEBORAH FARR, M.D.'s credentials?
DEBORAH FARR, M.D.'s NPI is 1700049566 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology